ArticleScience advances2026
Steering semi-flexible molecular diffusion model for structure-based drug design with reinforcement learning.
Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bidirectional cross-modal fusion with tensor interaction for drug-target binding prediction.Scientific reports · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Current structure-based molecular generation faces a fundamental dilemma: While static ligand modeling dominates computational approaches, real-world molecular interactions are inherently dynamic. Inspired by the conformational changes ligands undergo during semi-flexible docking, we propose a reinforcement learning (RL)-steered diffusion framework for semi-flexible molecular generation in protein pockets. By defining the denoising process as a Markov decision process, RL dynamically adjusts molecular structures through iterative exploration. Simultaneously, we incorporate multiple molecular properties as conditions to constrain the denoising policy to drug-like regions and perform self-supervised rigid training on both target-free and target-specific molecules. In addition, we propose a fast sampling strategy that accelerates sampling by 20 times, thereby improving the efficiency of training and sampling. Experiments demonstrate that our method outperforms state-of-the-art methods with a Vina score of -7.23 kcal/mol and an 11.53% success rate. Targeting unseen real-world proteins, the generated molecules preserve canonical interaction patterns while discovering previously unknown binding chemotypes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.